AIM ImmunoTech, Inc. (AIM)
0.2297
0.00 (0.00%)
USD |
NYAM |
Sep 08, 16:00
0.2334
0.00 (0.00%)
Pre-Market: 08:26
AIM ImmunoTech Market Cap : 6.659M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 6.659M |
| September 04, 2026 | 6.598M |
| September 03, 2026 | 6.775M |
| September 02, 2026 | 6.801M |
| September 01, 2026 | 6.842M |
| August 31, 2026 | 6.552M |
| August 28, 2026 | 7.491M |
| August 27, 2026 | 7.248M |
| August 26, 2026 | 7.248M |
| August 25, 2026 | 7.364M |
| August 24, 2026 | 7.364M |
| August 21, 2026 | 7.491M |
| August 20, 2026 | 7.337M |
| August 19, 2026 | 6.905M |
| August 18, 2026 | 6.781M |
| August 17, 2026 | 7.045M |
| August 14, 2026 | 6.375M |
| August 13, 2026 | 7.497M |
| August 12, 2026 | 7.450M |
| August 11, 2026 | 7.384M |
| August 10, 2026 | 7.624M |
| August 07, 2026 | 8.274M |
| August 06, 2026 | 7.850M |
| August 05, 2026 | 8.222M |
| August 04, 2026 | 2.163M |
| Date | Value |
|---|---|
| August 03, 2026 | 2.171M |
| July 31, 2026 | 2.086M |
| July 30, 2026 | 1.933M |
| July 29, 2026 | 1.974M |
| July 28, 2026 | 1.941M |
| July 27, 2026 | 2.056M |
| July 24, 2026 | 2.048M |
| July 23, 2026 | 2.056M |
| July 22, 2026 | 2.084M |
| July 21, 2026 | 2.048M |
| July 20, 2026 | 2.056M |
| July 17, 2026 | 2.114M |
| July 16, 2026 | 2.245M |
| July 15, 2026 | 2.122M |
| July 14, 2026 | 2.188M |
| July 13, 2026 | 2.188M |
| July 10, 2026 | 2.327M |
| July 09, 2026 | 2.384M |
| July 08, 2026 | 2.385M |
| July 07, 2026 | 2.512M |
| July 06, 2026 | 2.442M |
| July 02, 2026 | 2.303M |
| July 01, 2026 | 2.434M |
| June 30, 2026 | 2.336M |
| June 29, 2026 | 2.436M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.747B |
| Alnylam Pharmaceuticals, Inc. | 34.78B |
| Anika Therapeutics, Inc. | 281.58M |
| Savara, Inc. | 1.136B |
| Vericel Corp. | 2.000B |
Market Cap Related Metrics
| PS Ratio | 16.10 |
| Price to Book Value | 0.8599 |
| Price | 0.2297 |
| Earnings Yield | -1.67K% |